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s u m m a r y
We examined the doseeresponse relationship between long sleep duration and health outcomes
including mortality and the incidence of diabetes mellitus, hypertension, cardiovascular diseases, stroke,
coronary heart diseases, obesity, depression and dyslipidemia. We collected data from 5,134,036 par-
ticipants from 137 prospective cohort studies. For the independent variable, we categorized participants
at baseline as having long sleep duration or normal sleep duration. Risk ratios (RRs) for mortality and
incident health conditions during follow-up were calculated through meta-analyses of adjusted data
from individual studies. Meta-regression analyses were performed to investigate the association be-
tween each outcome and speciﬁc thresholds of long sleep. Long sleep was signiﬁcantly associated with
mortality (RR, 1.39; 95% CI, 1.31e1.47), incident diabetes mellitus (1.26, 1.11e1.43), cardiovascular disease
(1.25, 1.14e1.37), stroke (1.46, 1.26e1.69), coronary heart disease (1.24, 1.13e1.37), and obesity (1.08, 1.02
e1.15). Long sleep was not signiﬁcantly related to incident hypertension (1.01, 0.95e1.07). Insufﬁcient
data were available for depression and dyslipidemia. Meta-regression analyses found statistically sig-
niﬁcant linear associations between longer sleep duration and increased mortality and incident car-
diovascular disease. Future studies should address whether the relationship between long sleep and
health outcomes is causal and modiﬁable.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Short and long sleep duration have been associated with a range
of adverse health outcomes. The relationship between short sleep
duration and health outcomes has been examined more closely. A
causal relationship between short sleep duration and adverse
health outcomes is supported by meta-analyses of epidemiological
and cohort data [1,2], and by laboratory studies of experimental
sleep restriction and sleep deprivation [3,4]. Fewer studies have
addressed the relationship between long sleep duration and health
outcomes, despite the prevalence of long sleep. Long sleep dura-
tion, deﬁned more than 9 h of sleep, is prevalent in several devel-
oped countries, including Australia (an adjusted proportion of 33%
in 2006), Finland (38% in 1999), Germany (40% in 2001), the
Netherlands (25.7% in 2005), Sweden (30% in 2000), the U.K. (26%
in 2005) and the U.S. (38% in 2007), according to a study using a
data from time use survey [5]. A recent survey on behavioral risk
factors conducted in the U.S. revealed that approximately 8% of
adult respondents reported sleeping nine or longer hours [6].
Several systematic reviews have shown that long sleep duration
is associated with important health outcomes including not only
mortality [7e10] but also cardiovascular diseases [11], stroke
[12,13], and diabetes mellitus [14,15]. However, because these re-
views utilized different methodologies, we conducted a systematic
review using the same methodology across all health outcomes.
Abbreviations: CER, control event rate; CI, conﬁdence interval; HR, hazard ratio;
MOOSE, meta-analysis of observational studies in epidemiology; NOS, New-
castleeOttawa scale; OR, odds ratio; PRISMA, preferred reporting items for sys-
tematic reviews and meta-analyses; RR, risk ratio.
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This approachmay allow us to consider themagnitude of long sleep
duration effects on different health outcomes.
We have previously examined the association between short
sleep duration and important health outcomes, and observed sig-
niﬁcant associations with outcomes including mortality (risk ratio
(RR), 1.12; 95% CI, 1.08e1.16), diabetes mellitus (1.37, 1.22e1.53),
hypertension (1.17, 1.09e1.26), cardiovascular diseases (1.16,
1.10e1.23), coronary heart diseases (1.26, 1.15e1.38), and obesity
(1.38, 1.25e1.53) [16]. In the present study, we conducted a sys-
tematic review, meta-analyses and meta-regression to examine
whether long sleep duration is associated with adverse health
outcomes using the same methodology. Our method also allowed
us to explore the speciﬁc sleep duration that is associated with
these adverse health outcomes.
Methods
As described in our previous study on short sleep duration [16],
we performed the study in accordance with PRISMA (preferred
reporting items for systematic reviews andmeta-analyses) [17] and
MOOSE (meta-analysis of observational studies in epidemiology)
[18] guidelines; see Appendices S5 and S6 in Supplementary
material for PRISMA and MOOSE checklists.
Two independent researchers (OI and MJ) separately assessed
the eligibility, extracted data, and checked the quality of the
included studies. Any disagreements were resolved through dis-
cussion between these two, with adjudication by a third reviewer
(NW) if disagreements persisted.
Data sources and searches
The studieswere initially identiﬁedonOctober17, 2013, througha
searchofPubMed,PsycINFO, CINAHLandEmbaseusingpre-speciﬁed
search terms (Appendices S1eS4). The review was not limited to
English-language articles. We also hand-searched major medical
journals, conference proceedings, and reference lists of included
studies and previous systematic reviews for published, unpublished,
and ongoing studies. We conducted a search of PubMed using the
same search strategy on October 9, 2014 and on May 6, 2016, to
identify new studies published during the review process.
Study selection
We included studies that compared individuals with long and
“normal” sleep duration on outcomes of mortality and incident
health outcomes. All studies included long-term follow-up, used a
prospective cohort or randomized controlled trial design, and were
conducted in community settings. We limited studies to those with
a minimum follow-up duration of 1 y from baseline, and a mini-
mum of 20 participants. Studies were excluded if most participants
were aged 20 y or less at baseline, or if participants had been
diagnosed with the health outcome at baseline. We also excluded
studies that were conducted in inpatient settings and those that
involved pharmacological interventions.
The eligibility of each study for inclusion was checked at two
stages: 1) review of the title and abstract and 2) review of the full
text.
Data extraction and quality assessment
Deﬁnition of long duration
Long sleep duration was deﬁned in one of two ways for each
paper. For some papers, long sleep duration was deﬁned according
to the criteria established by that source paper, given that sleep
duration varies among cultures and ethnicities [19,20]. For papers
that did not establish a criterion, long sleep was deﬁned as the
longest sleep duration range reported for participants in the orig-
inal article. Durations of sleep in the deﬁnition of long sleep were
incorporated into subgroup analyses and meta-regression as me-
diators (see below). When both a self-report (e.g., sleep diary) and
objective (e.g., actigraphy or polysomnography) sleep duration
were reported, we selected the former as the independent variable.
Although self-report may capture a different amount of sleep per
night than actigraphy [21] or polysomnography [22], objective
measures are less commonly utilized in community settings,
making self-report measures more widely applicable. When both
sleep duration per night and per 24 h (i.e., including daytime naps)
were reported, we selected the former.
The duration of normal sleep was also deﬁned based on each
source paper, or deﬁned as the reference range for participants in
the original article.
Outcome measures
Outcome measures included mortality and incidence of adverse
health outcomes, speciﬁcally diabetes mellitus, hypertension, dys-
lipidemia (hypo or hyperlipidemia), cardiovascular diseases
(including events in the heart and brain), coronary heart diseases,
stroke, obesity, and depression. When a formal diagnosis was not
provided, a surrogate outcome (e.g., coronary artery calciﬁcation
instead of a diagnosis of coronary artery disease, or a self-report of
diabetes mellitus without evidence of formal diagnosis) was
included in the primary analyses, but a sensitivity analysis was also
conducted (see below).
Assessment of bias
We employed the NewcastleeOttawa scale (NOS) [23] to assess
the studies' quality. The instrument has three broad categories
(patient selection, four criteria; comparability of study groups, one
criterion; and assessment of the outcome, three criteria). For the
comparability criteria, we allotted two stars according to the depth
of statistical adjustment for risk factors in the original studies (e.g.,
one star for age, sex, and race only; two stars for further factors).
Therefore, a study could have a maximum quality rating of nine
stars. Although previous meta-analyses [24,25] deemed study
quality as high with ﬁve or more stars on the NOS criteria, we set a
threshold of eight or more stars, to focus on very high quality
studies.
We deﬁned adequate follow-up for each disorder in terms of
duration and % attrition (i.e., 3 y and 10% attrition for all-cause
mortality, cardiovascular diseases, and coronary heart disease;
and 2 y and 20% attrition for diabetes mellitus, hypertension, dys-
lipidemia, obesity, and depression).
Data synthesis and analysis
We analyzed data descriptively and conducted a meta-analysis
for each health outcome. In the meta-analysis, we calculated risk
ratios (RRs) by pooling adjusted RRs between long and normal
sleep provided by the original studies, using a random effects
model. If a study provided a point estimate and a p-value but not
conﬁdence intervals of RRs, the intervals were obtained using a
statistical method with log transformations of the estimate [26]. If
hazard ratios (HRs) were reported for a study but RRs were not, the
HRs were regarded as RRs. Among studies where odds ratios (ORs)
were provided but not RRs, we calculated RRs by using the ORs and
control event rates (CERs) in normal duration sleepers reported in
the original studies. For studies inwhich neither RRs nor CERs were
reported, and only ORs were provided, CERs were borrowed from a
study whose characteristics were similar. For studies in which RRs
were provided for subgroups separately (e.g., male and female),
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data from subgroups were combined using a ﬁxed-effect meta-
analysis.
Statistical heterogeneity between studies was investigated us-
ing the I2 statistic [27], assuming an I2 of 75% or greater to be an
important level of inconsistency, as employed by a previous review
[28]. To assess publication bias, we used a funnel plot and Egger's
test for all primary outcomes [29]. We used the “trim and ﬁll”
method to adjust the funnel plot, then recalculated results [30].
Because subgroup analyses should be interpreted with caution
[31], we planned a priori to limit our subgroup analyses to a small
number of baseline characteristics such as age and sex (i.e., be-
tween 20 and 65 y, or 65 y or more; male, or female).
Sensitivity analyses were planned a priori for the primary ana-
lyses set by: 1) excluding studies with surrogate outcomes; 2)
limiting studies to those in which sleep duration was reported per
night; 3) limiting analyses to studies with eight or more stars in the
NOS; 4) limiting studies to those with 10 or more y of follow-up;
and 5) excluding studies in which CERs from other studies were
used to calculate RRs.
In order to explore possible mediation by the deﬁnition of long
sleep, additional subgroup analyses were conducted by clustering
studies according to the deﬁnition of long sleep (e.g., more than 9 h
or more than 10 h). When studies were clustered into three or more
levels of sleep duration for each outcome, meta-regression analyses
were also performed. These analyses examined linear associations
between sleep duration and the outcome of interest, using a
random-effects model and illustrating the regression line and its
95% prediction intervals.
A p-value of less than 0.05 was chosen to test null hypotheses,
despite multiple comparisons, in order to avoid type II over type I
errors. For all outcomes, 95% conﬁdence intervals (CIs) were
calculated. The datawere analyzed using the ComprehensiveMeta-
Analysis Software (Version 3) [32].
Results
Search results
The initial electronic search yielded 3580 articles, and an
additional database search identiﬁed 182 studies on October 9,
2014 and 388 on May 6, 2016. In total, 2521 studies remained
after removing duplicate articles. A hand-search did not identify
any studies that had not been included in the electronic search
(Fig. 1). At the ﬁrst and second eligibility check stages, two in-
dependent researchers identiﬁed 277 articles and 95 articles,
respectively.
Characteristics of included studies
All of the 95 included studies were prospective cohort studies.
From these, 137 datasets for nine outcomes (N ¼ 5,134,036) were
collected. Most studies were conducted in developed countries (see
Table 1 and Tables S1eS9 in Supplementary material). The number
of participants in each dataset ranged from 276 to 392,164; the
duration of follow-up was from 1 to 34 y; and the total NOS scores
ranged from ﬁve to nine. Although the deﬁnition of long sleep
varied among studies, most deﬁned long sleep as greater than 8 or
9 h.
We were unable to pool data from six datasets in meta-analyses
because no usable data for meta-analyses were provided
(Table S10). The number of datasets included in the meta-analyses
for each outcome varied from 8 (hypertension) to 36 (mortality).
Table 1 shows the characteristics of studies included for the mor-
tality outcome.
Effect estimates of long sleep compared to normal sleep from meta-
analyses
Primary analyses
Compared with normal sleep duration, long sleep duration was
associated with a statistically signiﬁcant increase in all-cause
mortality, with an RR of 1.39 (95% CI ¼ 1.31e1.47, P < 0.001,
I2 ¼ 83%, N of datasets ¼ 36; Fig. 2). Qualitatively similar signiﬁcant
results were obtained for incident diabetes mellitus (RR¼ 1.26, 95%
CI ¼ 1.11e1.43, P < 0.001, I2 ¼ 63%, N ¼ 16), cardiovascular disease
(RR ¼ 1.25, 95% CI ¼ 1.14e1.36, P < 0.001, I2 ¼ 81%, N ¼ 25), stroke
(RR ¼ 1.46, 95% CI ¼ 1.26e1.69, P < 0.005, I2 ¼ 71%, N ¼ 14), cor-
onary heart disease (RR ¼ 1.24, 95% CI ¼ 1.13e1.37, P ¼ 0.003,
I2 ¼ 54%, N ¼ 19), and obesity (RR ¼ 1.08, 95% CI ¼ 1.02e1.15,
P ¼ 0.010, I2 ¼ 0%, N ¼ 13) (Fig. 3). Long sleep duration was not
associated with a statistically signiﬁcant increase in incident hy-
pertension compared to normal sleep duration (RR ¼ 1.01, 95%
CI ¼ 0.95e1.07, P ¼ 0.309, N ¼ 8). Substantial heterogeneity be-
tween datasets was observed in mortality and cardiovascular dis-
ease outcomes. Only one study each was identiﬁed for depression
and dyslipidemia outcomes, and RRs were not provided in the
source studies.
Possible publication bias for primary analyses
No signiﬁcant publication bias was observed for any outcome in
the funnel plots or results from Egger's test (see Figs. S2, S11, S22,
S32, S42, S52, and S63 in Supplemental material).
Subgroup analyses for age groups
Subgroup analyses were conducted for participants aged
65 y or <65 y at baseline (Fig. 3). Compared to normal sleep
duration, long sleep duration was associated with a signiﬁcant in-
crease in the incidence of cardiovascular disease and coronary heart
disease among those 65 y, but not among those <65 y. On the
other hand, long sleep duration was associated with a signiﬁcant
increase in incident obesity only among participants <65 y, and not
among those 65 y.
Subgroup analyses for sex
In comparison with normal sleep duration, long sleep duration
was associated with a signiﬁcant increase in mortality and incident
diabetes, cardiovascular disease, stroke, and coronary heart disease
for both men and women. Long sleep duration was associated with
a signiﬁcant increase in incident obesity only among female (Fig. 3).
Sensitivity analyses
Most sensitivity analyses showed qualitatively similar results to
those in the primary analyses (Fig. 3). Analyses limited to high
quality studies based on the NOS (>8 stars) and to studies with
follow-up greater than 10 y did not show statistically signiﬁcant
ﬁndings for incident diabetes (High-quality studies: RR ¼ 1.13,
0.94e1.35, P ¼ 0.191; Long follow-up studies: 1.97, 0.96e4.05,
P ¼ 0.064), or incident obesity (High-quality studies: RR 0.94,
0.40e2.24, P ¼ 0.896; Long follow-up studies: 1.04, 0.95e1.13,
P ¼ 0.441).
Subgroup analyses and meta-regression for speciﬁc values of long
sleep duration
Subgroup analyses for speciﬁc values of long sleep duration
were conducted for outcomes other than depression and dyslipi-
demia (Fig. 4). In comparison with normal sleep duration, long
sleep duration deﬁned as >8 h was associated with a signiﬁcant
increase in mortality, stroke, and coronary heart disease; long sleep
deﬁned as >9 h was associated with an increase in incident
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Fig. 1. Flowchart for the included studies. An arrow indicates that the upper limit of the 95% CI is over the scale described here.
M. Jike et al. / Sleep Medicine Reviews 39 (2018) 25e3628
Table 1
Characteristics of studies for mortality outcome.
Study Sample size Male% Mean age ± SD (range) in
years at baseline
Years of follow








Tsubono 1993 [53] 4318 39.8 61.4 (40) 4 7e8/night 9/night ++*+/++/+++
Kojima 2000 [54] 5322 45.8 Male: 46.9 (20e67),
Female: 47.7 (20e67)
11.9 7.0e8.9/night 10/night *+*+/++/+++
Seki 2001 [55] 1065 41.3 65.3 ± 3.6 (60e74) 7.5 7/d 9/d ++*+/++/+++










25 7e8/d >8/d ++*+/++/+++
Mallon 2002 [57] 1870 48.4 56 (45e65) 12 6e8/night >8/night ++*+/+*/+++
Burazeri 2003 [58] 1842 45.7 Male: median 64 (50),
Female: median 63 (50)
9e11 6e8/night >8/night ++*+/++/+++
Goto 2003 [59] 724 34.7 Male: median 73 (65e97),
Female: median 74 (65e97)
12 6e7/d >7/d ++++/++/+++
Amagai 2004 [60] 11,325 39.0 55.1 (19e93) 8.2 ± 1.5 7.0e7.9/night 9/night ++++/++/+++
Patel 2004 [61] 82,969 0.0 53.4 (40e65) 14 7/d 9/d *+*+/++/+++
Tamakoshi 2004 [62] 104,010 42.2 56.6 (40e79) 9.9 7/d 10/d ++**/++/+++
Ferrie 2007 [63] Phase 1: 9781
Phase3: 7729
NS (35e55) Phase 1: 17.1
Phase 3: 11.8
7/night 9/night *+*+/++/+++
Lan 2007 [64] 3079 56.8 Male: 71.3 (64),
Female: 71.9 (64)
8.4 ± 3.3 7e7.9/night 10/night ++++/++/+++
Gangwisch 2008 [65] 9789 37.2 Male; 45.0 (32e59),
Female; 73.0 (60e86)
8, 10 7/night 9/night ++++/++/+++
Ikehara, 2009 [66] 98,634 42.1 Male; 58.8 (40e79),
Female; 60.2 (40e79)
Median 14.3 7/d 10/d ++*+/++/+++
Stone 2009 [67] 8101 0.0 77.0 (69) 6.9 6e8/night >8/night ++++/++/+++
Suzuki 2009 [68] 12,601 51.1 74.1 ± 5.4 (65e85) 5.3 7/d 10/d *+*+/++/+++
Chien 2010 [69] 3430 47.3 (35) 15.9 (13.1e16.9) 7/d 9/d ++*+/++/+++
Mesas 2010 [70] 3820 43.8 71.8 ± 7.9 (60) 6.8 7/d 11/d ++*+/++/+++
Castro-costa 2011 [71] 1512 38.3 68.9 ± 7.1 (63e75) 7.5 Median: 8.9 7e8/night 9/night ++++/++/+++
Kripke 2011 [72] 434 0.0 67.6 ± 7.9 (50e81) 10.5 5e6.5/d >6.5/d ++++/**/+++
Kronholm 2011 [73] 23,290 48.8 (25e64) 29e34 7e8/night 10/night ++*+/++/+++
Cohen-Mansﬁeld
2012 [74]
1166 55.5 83.4 ± 5.3 (75e94) 20 7e9/night >9/night ++*+/++/+++
Chen 2013 [75] 4064 55.8 73.8 ± 5.7 (65) 9 7/night 9/night ++++/++/+++
Garde 2013 [76] 4941 100.0 (40e59) 30 6e7/d 8/d *+++/++/+++
Hale 2013 [77] 3942 0.0 62.1 (50e79) 11e16 7e8/night 9/night ++*+/++/+++
Kakizaki 2013 [78] 49,256 48.2 (40e79) 10.8 7/d 10/d ++*+/++/+++
Kim 2013 [79] 135,685 45.6 (45e75) 12.9 7/d 9/d ++*+/++/+++
Li 2013 [80] 9455 (38.1) (20e79) 7 7/night 9/night ++*+/++/+++
Magee 2013 [81] 227,815 46.3 (45) 2.8 7/d 10/d ++*+/++/+*+
Yeo 2013 [82] 13,164 41.4 (20) 9.44 7/d 10/d ++++/++/+++
Bellavia 2014 [83] 70,973 53.3 (45e83) 15 6.6e7.4/d >8/d ++*+/++/+++
Lee 2014 [84] 3427 50.9 (65) 5.1 ± 0.9 <10/night 10/night *+*+/++/+++
Rod 2014 [85] 9098 67.2 45 (35e55) 22 7/night >9/night *+*+/++/+++
Xiao 2014 [86] 239,896 56.2 (51e72) 14 7e8/night 9/night ++*+/++/++*
Zuurbier 2015 [87] 1734 46.6 62.2 ± 9.3 (45e98) 7.3 ± 1.3 6e7.5/night >7.5/night *+++/++/+++
Hall 2015 [88] 3013 48.6 73.6 ± 2.9 (70e79) 8.2 ± 2 0.3 7e8/night >8/night ++++/++/+++





















cardiovascular disease. Similar ﬁndings were not observed for
diabetes and obesity outcomes.
Meta-regression analyses were performed for mortality, dia-
betes, cardiovascular disease, stroke, coronary heart disease, and
obesity outcomes. Longer sleep duration was signiﬁcantly associ-
ated in a gradient fashion with increased mortality (coefﬁcient ¼
0.120, P < 0.0001, R2 analog¼ 0.03, Fig. 5). The 95% CIs of prediction
curves were greater than zero beginning at a sleep duration of
>9.5 h. Longer sleep duration was also associated in a gradient
fashion with incident cardiovascular disease (coefﬁcient ¼ 0.165,
P ¼ 0.002, R2 analog ¼ 0.05, Fig. S40). No signiﬁcant gradient as-
sociations were observed for the other outcomes.
Discussion
To the best of our knowledge, this is the ﬁrst systematic review
to investigate associations between long sleep duration and mul-
tiple health outcomes using the same methodology for each meta-
analysis, and to explore the doseeresponse of long sleep duration
on these outcomes using meta-regression analyses. Long sleep
duration was associated with greater mortality and increased
incidence of multiple health conditions. The strength of association
varied across outcomes, with a point estimate RR of 1.46 for stroke,
1.39 for mortality, 1.26 for diabetes mellitus, 1.25 for cardiovascular
disease, 1.24 for coronary heart disease and 1.08 for obesity. Long
Risk ratio and 95% CI
Risk LowerUpper
ratio limit limit
Tsubono 1993 [53] 1.58 1.16 2.15
Kojima 2000 [54] 1.49 0.78 2.88
Seki 2001 [55] 0.97 0.50 1.89
Heslop 2002 [56] 0.92 0.80 1.06
Mallon 2002 [57] 1.75 1.16 2.63
Burazeri 2003 [58] 1.38 1.33 1.44
Goto 2003 [59] 1.46 1.05 2.03
Amagai 2004 [60] 1.24 0.94 1.63
Patel 2004 [61] 1.40 1.26 1.56
Tamakoshi 2004 [62] 1.88 1.63 2.17
Ferrie 2007 [63] 1.81 1.17 2.78
Lan 2007 [64] 1.69 1.40 2.05
Gangwisch 2008 [65] 1.34 1.15 1.56
Ikehara 2009 [66] 1.47 1.37 1.57
Stone 2009 [67] 1.16 0.97 1.39
Suzuki 2009 [68] 1.96 1.49 2.57
Chien 2010 [69] 1.34 1.08 1.67
Mesas 2010 [70] 1.66 1.23 2.24
Castro-costa 2011 [71] 1.53 1.12 2.09
Kronholm 2011 [73] 1.61 1.25 2.09
Cohen-Mansfield 2012 [74] 1.32 1.10 1.59
Chen 2013 [75] 1.66 1.27 2.16
Garde 2013 [76] 0.99 0.87 1.13
Hale 2013 [77] 1.50 0.93 2.41
Kakizaki 2013 [78] 1.37 1.27 1.47
Kim 2013 [79] 1.20 1.15 1.26
Li 2013 [80] 1.76 1.25 2.50
Magee 2013 [81] 1.26 1.16 1.36
Yeo 2013 [82] 1.36 1.07 1.72
Bellavia 2014 [83] 1.23 1.15 1.32
Lee 2014 [84] 1.90 1.24 2.93
Rod 2014 [85] 1.46 0.77 2.75
Xiao 2014 [86] 1.11 1.05 1.18
Cai 2015 [87] 1.81 1.64 2.00
Hall 2015 [88] 1.23 0.93 1.63





Favors long sleep   Favors normal sleep
duration           duration
Fig. 2. Mortality outcome comparing long with normal sleepers. An arrow indicates that the upper limit of the 95% CI is over the scale described here.
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sleep duration was not signiﬁcantly associated with increased risk
of hypertension, and available evidence was not sufﬁcient to
examine depression and dyslipidemia outcomes.
The present results are similar to those from previous system-
atic reviews. For instance, long sleep duration has been associated
with a RR of 1.23 (N of studies ¼ 17) [7] and 1.30 (N ¼ 16) [8] for
mortality; with a RR of 1.41 (N ¼ 8) for cardiovascular disease [11];
and with an HR of 1.46 for stroke (N ¼ 11) [12]. Our ﬁndings
contribute important new information to previous reviews because
of our updated comprehensive literature search and our use of the
same rigorous methodology for each outcome. However, further
epidemiological studies will be needed to investigate the associa-
tion of long sleep with dyslipidemia and depression.
The lack of a statistically signiﬁcant association between long
sleep duration and hypertension (RR 1.01, 0.95e1.07) is consistent
with ﬁndings in a previous review (1.02, 0.91e1.14) [33]. On the
other hand, our ﬁndings differ from previous results for the obesity
outcome; we found that long sleep was signiﬁcantly associated
with obesity (RR 1.08, 1.02e1.15, P ¼ 0.010), whereas a previous
review did not ﬁnd a statistically signiﬁcant association (odds ratio
1.06, 0.98e1.15) [34]. This discrepancy may partly be due to
different statistical methodologies, but we also observed narrower
conﬁdence intervals, which is likely due to our inclusion of 15
datasets compared to 10 in the previous review.
In subgroup analyses addressing speciﬁc thresholds for long
sleep duration, values greater than 8 or 9 h were associated with
signiﬁcantly increased mortality and cardiovascular disease in
comparisonwith normal sleep. In meta-regression, longer duration
of sleep was linearly associated with increasedmortality risk. These
ﬁndings are again consistent with those in previous studies [9,10].
Although the American Academy of Sleep Medicine and the Sleep
Research Society have not published their recommendations for an
upper limit of appropriate sleep duration, the National Sleep
Foundation issued its recommendations, including 8e10 h for
teenagers (aged 14e17 y), 7e9 h for adults (18e64 y) and 7e8 h for
older adults (65) [35]. Normative total sleep time is reported to
decrease with age not only in adolescents but also in adults [36],
and most participants included in the present study were aged
between 30 and 70 y. The recommendations match well with the
results from our analyses.
The ﬁndings of the present study complement those of our
previous review on short sleep duration [16]. Using identical
methodology to that in the current study, we found that sleep
duration <6 h is associated with a signiﬁcant increase in mortality
and health outcomes such as diabetes, cardiovascular disease,
coronary heart disease, and obesity. In combination, the ﬁndings of
these two papers are consistent with the “U-shaped” relationship
between sleep duration and multiple health outcomes that has
been previously described. However, we did not directly test
curvilinear relationships in these papers. Moreover, the strength of
associationwith sleep duration varies among the various outcomes,
as described above.
Although several theoretical pathways may explain the rela-
tionship between long sleep duration and health outcomes [37],
our study was unable to examine speciﬁc mechanisms. Moreover,
we do not have data showing that changing sleep duration
modiﬁes health risks. Therefore, while we can conﬁdently state
that long sleep duration is a risk factor for adverse health out-
comes, we cannot demonstrate that it is a causal risk factor [38].
Nevertheless, ﬁndings from our studies on the health risks of
short and long sleep duration may encourage both mechanistic
studies and intervention studies to investigate whether and how
sleep duration confers health risk. Regarding education, psycho-
therapy, and psychosocial interventions, many studies have
focused on insomnia and the efﬁcacy of these interventions on the
quality of sleep has been reported in recent systematic reviews
[39,40]. To the best of our knowledge, there is no evidence base to
test these interventions in the community for prevention of the
health outcomes. Until such studies are conducted, our ﬁndings
may be used in education and health literacy efforts to encourage
adequate duration of sleep as a key component of overall sleep
health [41].
Limitations of the study
Although our ﬁndings are internally consistent and consistent
with previous studies, we acknowledge several limitations.
First, our analyses focused on night-time sleep rather than on
24-h sleep. Given the number of primary, subgroup, and sensitivity
analyses, we were concerned about inﬂating the risk of type I er-
rors. A previous systematic review conducted meta-analyses using
both night-time and 24-h sleep [9], and reported similar ﬁndings
with regard to all-cause mortality. Therefore, we believe that our
decision to focus on night-time sleep is unlikely to have had amajor
effect on our conclusions.
Secondly, we collected most of the data on sleep duration based
on results from an interview question or a questionnaire, or from a
sleep diary, but not from objective measures (e.g., actigraphy or
polysomnography), because we believed that self-reported mea-
sures were more widely utilized and applicable than objective
measures in community settings. However, sleep duration assess-
ment based on a simple question, sleep diary, and objective mea-
sures have been reported to be inconsistent [42,43]. In addition, the
term “sleep duration” has been sometimes used as the amount of
time in bed in previous epidemiological studies [44]. The deﬁnition
of sleep duration utilized in our systematic review relies on the
deﬁnition used in original studies and different measurement ap-
proaches might lead to discrepancies among the included studies,
although we have extracted data on actual sleep duration with the
utmost care and attention.
Thirdly, we did not investigate the impact of other di-
mensions of sleep, such as subjective or objective sleep quality,
on health outcomes. Although previous studies have reported
an association between sleep problems such as insomnia and
mortality [45,46], we intended to focus on the duration of sleep
because it is likely that sleep duration is more easily recognized
and accurately reported by participants rather than the quality
of sleep, in community surveys. However, we believe that in-
terventions to reduce unwanted health outcomes should
include information not only about sleep duration but also
about the quality of sleep, because the latter may be an
important factor in mechanisms linking sleep and subsequent
health outcomes.
Fourthly, we have done our meta-analyses by pooling adjusted
RRs between long and normal sleep as provided by the original
studies. However, we were dependent on the original studies as to
whether types of confounders had been adjusted or not, and some
important confounders, including employment status, depression
and excessive amounts of time in bed, were not adjusted in all
studies (Tables S1eS9). This is a limitation of meta-analyses pooling
aggregated data.
Fifthly, we recognize that the role of individual differences
regarding sleep duration preferences is still uncertain [47], and that
the reasons for different durations of sleep vary from person to
person. Previous epidemiological studies have shown that short
sleep duration is associated with characteristics such as being un-
married [48], more frequent binge drinking [49], lower socioeco-
nomic status [49,50], lower education levels [50], working multiple
jobs [51], pre- and post-sleep activities including socializing, self-
care and hygiene, and watching TV [51] and African, Asian and
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N of  




All 36 1.39 1.31 1.47
Aged 65 y or more 8 1.51 1.30 1.75
Aged under 65 y 9 1.26 1.05 1.52
Female 19 1.48 1.36 1.61
Male 17 1.39 1.24 1.56
Sleep defined by night 20 1.41 1.30 1.53
High quality on the NCO scale 26 1.35 1.27 1.44
Follow-up no less than 10 y 18 1.29 1.20 1.38
Non barrowed prevalence rate 36 1.39 1.31 1.47
Diabetes
All 16 1.26 1.11 1.43
Aged under 65 y 6 1.32 1.02 1.71
Female 2 1.31 1.06 1.61
Male 1 3.12 1.53 6.37
Sleep defined by night 9 1.38 1.17 1.63
High quality on the NCO scale 6 1.13 0.94 1.35
Follow-up no less than 10 y 3 1.97 0.96 4.05
Non barrowed prevalence rate 12 1.26 1.11 1.43
True outcome 11 1.30 1.08 1.57
Hypertension
All 8 1.01 0.95 1.07
Aged 65 y or more 1 0.89 0.77 1.03
Aged under 65 y 6 1.00 0.93 1.07
Female 5 0.99 0.94 1.05
Male 4 0.98 0.80 1.21
Sleep defined by night 6 1.00 0.95 1.05
High quality on the NCO scale 3 0.94 0.78 1.13
Non barrowed prevalence rate 8 1.01 0.95 1.07
True outcome 6 1.01 0.91 1.12
Cardiovascular disease
All 25 1.25 1.14 1.37
Aged 65 y or more 3 1.59 1.17 2.16
Aged under 65 y 10 1.19 0.94 1.50
Female 14 1.48 1.28 1.71
Male 13 1.31 1.17 1.47
Sleep difined by night 12 1.33 1.21 1.47
High quality on the NCO scale 15 1.23 1.10 1.38
Follow-up no less than 10 y 18 1.18 1.07 1.30
True outcome 9 1.07 0.93 1.23
Stroke
All 14 1.46 1.26 1.69
Aged under 65 y 3 1.56 1.23 1.98
Female 8 1.67 1.31 2.12
Male 8 1.37 1.19 1.57
Sleep defined by night 5 1.51 1.30 1.75
High quality on the NCO scale 9 1.41 1.15 1.73
Follow-up no less than 10 y 8 1.32 1.11 1.56
True outcome 7 1.35 1.06 1.71
Coronary heart disease
All 19 1.24 1.13 1.37
Aged 65 y or more 1 1.44 1.13 1.84
Aged under 65 y 8 1.10 0.93 1.30
Female 10 1.46 1.24 1.71
Male 9 1.29 1.09 1.52
Sleep difined by night 10 1.24 1.10 1.40
High qulatiy on the NCO scale 11 1.26 1.13 1.41
Follow-up no less than 10 y 15 1.24 1.10 1.39
Non borrowed prevalence rate 18 1.23 1.12 1.35
True outcome 11 1.20 1.06 1.36
Obesity
All 13 1.08 1.02 1.15
Aged 65 y or over 1 1.45 0.87 2.42
Aged under 65 y 8 1.09 1.00 1.18
Female 6 1.12 1.00 1.26
Male 8 1.10 0.97 1.25
Sleep difined by night 4 1.21 0.99 1.47
High quality on the NCO scale 2 0.94 0.40 2.22
Follow-up no less than 10 y 2 1.04 0.95 1.13
Non borrowed prevalence rate 6 1.06 0.99 1.13
True outcome 8 1.09 0.95 1.25
0.5 1 2
Favors long sleep   Favors normal sleep
duration            duration
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Hispanic ethnicity [50]. On the other hand, characteristics related to
long sleep duration include Mexican ethnicity, public liability in-
surance [50], and less weekly physical activity [52]. Some of these
characteristics, such as working multiple jobs, may present barriers
for possible interventions aimed at sleep duration because of eco-
nomic disincentives. However, other characteristics associatedwith
sleep duration may be more amenable to change, including
frequent binge drinking, the amount of physical activity, and using
smart phones and television viewing prior to sleeping. Future
studies focusing on sleep duration must also account for individual
preferences.
Finally, shorter or longer periods of sleep duration are unlikely
to link directly to sleep disorders such as sleep apnea or insomnia.
Therefore, our ﬁndings are likely to have limited comparability
with ﬁndings derived from patients seeking treatment in clinical
settings.
Fig. 3. Relative risks of mortality and health outcomes comparing long with normal sleepers. NCO scale, NewcastleeOttawa Scale. For the outcomes of dyslipidemia and depression,
no meta-analyses were performed. An arrow indicates that the upper limit of the 95% CI is over the scale described here.
Fig. 4. Subgroup analyses for duration thresholds of long sleep. An arrow indicates that the upper limit of the 95% CI is over the scale described here.
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Conclusions
Long sleep durationwas associated with a signiﬁcant increase in
risk for mortality and incident diabetes, cardiovascular disease,
stroke, coronary heart disease, and obesity. Future studies should
address potential mechanisms underlying the relationship be-
tween long sleep duration and adverse health outcomes. Whether
interventions to reduce long sleep duration also reduce health risk
remains an open question.
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